In stressed adult male Sprague–Dawley rats, LY341495 reversed decreased sucrose preference at 48 hrs compared with the Stress/Vehicle group, with the effect sustained for 10 days. In male APP/PS1 transgenic mice, daily intraperitoneal LY341495 treatment improved the NOR discrimination index significantly compared with vehicle and also significantly improved the NLR discrimination index. In male Sprague–Dawley rats, LY341495 perfusion into the MDTN did not affect local glutamate levels. [1,2,3]
Literature-reported observations and conditions; not Adooq-tested protocols or general treatment recommendations.
Sucrose Preference Following Stress in Rats
Animal study · Adult male Sprague–Dawley rats (Charles River) [1]
Adult male Sprague–Dawley rats received a single intraperitoneal injection of LY341495 at 3 mg/kg after stress. Compared with the Stress/Vehicle group, treatment showed a nonsignificant trend toward reversal of decreased sucrose preference at 24 hrs and reversed the decrease at 48 hrs, with the effect sustained for 10 days.
Conditions shared by the study groups
- Route
- intraperitoneal (i.p.) injection
- Treatment course
- After 28 days of stress; a single intraperitoneal (i.p.) injection; tested 24 hrs, 48 hrs, and 10 days after drug administration.
- Vehicle
- saline
- LY341495 3 mg/kg
- Model: Adult male Sprague–Dawley rats (Charles River)
Methods and source locations
Compound reported in the paper: LY341495
Literature evidence for the named compound in the stated model; no Adooq product-use or lot-performance claim.
Methods (S1, S4, S6, S7); Figure 1 legend (S10, S11); Figure 2 legend (S12)
sucrose preference: sucrose preference; comparator: Stress/Vehicle group — Figure 1 legend (S10, S11); Figure 2 legend (S12)
LY341495 3 mg/kg · Methods (S4, S6, S7); Figure 1 legend (S10, S11); Figure 2 legend (S12)
Novel Object Recognition Discrimination in Transgenic Mice
Animal study · Male APP/PS1 transgenic mice [2]
Male APP/PS1 transgenic mice received daily intraperitoneal injections of LY341495 at 1.0 mg/kg for 7 consecutive days. The NOR discrimination index improved significantly compared with the vehicle group.
Conditions shared by the study groups
- Route
- intraperitoneal injections
- Treatment course
- daily intraperitoneal injections of either LY341495 or vehicle for 7 consecutive days
- Vehicle
- saline
- LY341495 1.0 mg/kg
- Model: Male APP/PS1 transgenic mice
Methods and source locations
Compound reported in the paper: LY341495
Literature evidence for the named compound in the stated model; no Adooq product-use or lot-performance claim.
Materials and Methods > Animals (S1); Materials and Methods > Drug Administration (S5, S6); Materials and Methods > Behavioral Tests (S10); FIGURE 1 legend (S139)
Discrimination index for NOR: Discrimination index for NOR; comparator: APP/PS1 + Vehicle — FIGURE 1 legend (S139)
LY341495 1.0 mg/kg · Materials and Methods > Drug Administration (S5); Materials and Methods > Behavioral Tests (S10); FIGURE 1 legend (S139)
Basal Extracellular Glutamate Following MDTN Perfusion in Rats
Animal study · Male Sprague‐Dawley rats [3]
Male Sprague–Dawley rats received LY341495 at 1 μmol L−1 by perfusion into the MDTN. LY341495 perfusion did not affect glutamate levels in the MDTN.
Conditions shared by the study groups
- Route
- into the MDTN
- Vehicle
- dimethyl sulfoxide
- LY341495 1 μmol L−1
- Model: Male Sprague‐Dawley rats
- Reported limits: Not stated in the sentences used: schedule.
Methods and source locations
Compound reported in the paper: LY341495
Literature evidence for the named compound in the stated model; no Adooq product-use or lot-performance claim.
MATERIALS AND METHODS > Chemical agents (S5, S6); MATERIALS AND METHODS > Preparation of the microdialysis system (S11); RESULTS > Roles of Sxc, II‐mGluR, III‐mGluR, and GABAA receptor in the MDTN on mPFC MK801‐induced glutamate rise and MDTN MK801‐induced GABA reduction (S81); Figure 3 legend (S111)
basal extracellular glutamate level: basal extracellular glutamate level; comparator: levels of MK801 pre‐perfusion of control — RESULTS > Roles of Sxc, II‐mGluR, III‐mGluR, and GABAA receptor in the MDTN on mPFC MK801‐induced glutamate rise and MDTN MK801‐induced GABA reduction (S81); Figure 3 legend (S111)
LY341495 1 μmol L−1 · RESULTS > Roles of Sxc, II‐mGluR, III‐mGluR, and GABAA receptor in the MDTN on mPFC MK801‐induced glutamate rise and MDTN MK801‐induced GABA reduction (S81)
Novel Location Recognition Discrimination in Transgenic Mice
Animal study · Male APP/PS1 transgenic mice [2]
Male APP/PS1 transgenic mice received daily intraperitoneal injections of LY341495 at 1.0 mg/kg for 7 consecutive days. The NLR discrimination index improved significantly following treatment.
Conditions shared by the study groups
- Route
- intraperitoneal injections
- Treatment course
- daily intraperitoneal injections of either LY341495 or vehicle for 7 consecutive days
- Vehicle
- saline
- LY341495 1.0 mg/kg
- Model: Male APP/PS1 transgenic mice
Methods and source locations
Compound reported in the paper: LY341495
Literature evidence for the named compound in the stated model; no Adooq product-use or lot-performance claim.
Materials and Methods > Animals (S1, S3); Materials and Methods > Drug Administration (S5, S6); Materials and Methods > Behavioral Tests (S10); FIGURE 1 legend (S140)
Discrimination index for NLR: Discrimination index for NLR; comparator: APP/PS1 + Vehicle — FIGURE 1 legend (S140)
LY341495 1.0 mg/kg · Materials and Methods > Drug Administration (S5); Materials and Methods > Behavioral Tests (S10); FIGURE 1 legend (S140)